INTRAFRACTION PROSTATE MOTION MANAGEMENT
The raypilot system
Enabling accuracy in prostate cancer care
The Raypilot System is an electromagnetic positioning system that continuously localizes the prostate during radiation therapy. The system includes a transmitter which tracks the prostate tumour movements and outlines the urethra in real-time 3D, thus enhancing treatment precision and enabling a significant reduction of the risk of damaging surrounding healthy tissue. The precision makes it possible to use higher radiation dose and treatment may be given in a week or less, compared to conventional therapy over an 8-week period.
Healthcare professionals about Raypilot
“The reported significantly increased toxicity for SBRT vs standard IMRT was mostly urethra related. Having the possibility to identify the urethra using the Raypilot Hypocath gives us the opportunity to reduce the urethral dose without underdosing the tumour, thus delivering a safer treatment.”
Medical Physicist Denis Panizza, San Gerardo Hospital, Monza, Italy
“Raypilot Hypocath enables us to keep track of prostate motion during SBRT treatments where the precise dose to the target and strict tolerance to the surrounding organs is paramount.”
Professor Stefano Arcangeli, Head of Radiation Oncology, San Gerardo Hospital, Monza, Italy
BENEFITS
PATIENT STORIES
– I have not had any side effects. My way of life hasn´t changed at all.
Mr Cattaneo Giorgio, treated at San Gerardo Hospital in Monza, Italy.
Meet 79-year-old Mr Cattaneo Giorgio. He was treated for prostate cancer in four sessions performed in four consecutive days. The use of Raypilot allows faster as well as more effective and safe treatments.
-
Interim Toxicity Analysis From the Randomized HERMESTrial of 2- and 5-Fraction Magnetic Resonance Imaging−Guided Adaptive Prostate Radiation Therapy
latest publications
-
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial
Read article
-
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial
Read article
-
News
Micropos Medical Receives MDR Certification
We are proud to announce that Micropos Medical AB has received the MDR as well as the UKCA certificate for the Raypilot System. This certification confirms that Micropos Medical’s Raypilot System is […]
Events
The Future Is Here: Discover What Leading Clinics Are Doing Today
Join us for an exclusive morning event for medical professionals. Learn firsthand about the latest innovations in radiotherapy, hear from leading clinicians and patients treated with ASBRT, and explore how […]
Edinburgh, United Kingdom
Edinburgh, United Kingdom
NEWSLETTER
Follow us on LinkedIn
Let’s keep in touch